Expression and cellular localization of the CC chemokines PARC and ELC in human atherosclerotic plaques

American Journal of Pathology

Volumn 154, Issue 2, 1999, Pages 365-374

  Reape, Theresa J ^a   Rayner, Kim ^a   Manning, Carol D ^a   Gee, Andrew N ^a   Barnette, Mary S ^a   Burnand, Kevin G ^b   Groot, Pieter H E ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; EBI1 LIGAND CHEMOKINE; PULMONARY AND ACTIVATION REGULATED CHEMOKINE; UNCLASSIFIED DRUG;

ARTICLE; ATHEROSCLEROTIC PLAQUE; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

EID: 0032915954     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65283-2     Document Type: Article

References (40)

1. Yokota T, Hansson GK: Immunological mechanisms in atherosclerosis. J Int Med 1995, 238:479-489
2. Watanabe T, Haraoka S, Shimokama T: Inflammatory and immunological nature of atherosclerosis. Int J Cardiol 1996, 54:S51-S60
3. Hansson GK, Holm J, Jonasson L: Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol 1989, 135: 169-175
4. + T cells infiltrate lesions of apolipoprotein-E-Deficient Mice. Am J Pathol 1996, 149:359-366
5. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801-809
6. Graves DT, Jiang Y: Chemokines a family of chemotactic cytokines. Crit Rev Oral Biol Med 1995, 6:109-118
7. Baggiolini M: Chemokines and leukocyte traffic. Nature 1998, 392: 565-568
8. Kennedy J, Kelner G, Kleyensteuber S, Schall TJ, Weiss MC, Yssel H, Schneider PV, Cocks BG, Bacon KB, Zlotnik A: Molecular cloning and functional characterization of human lymphotactin. J Immunol 1995, 155:203-209
9. 3C motif. Nature 1997, 385:640-644
10. Robinson EA, Yoshimura T, Leonard EJ, Tanaka S, Griffen PR, Snabanowitz J, Hunt DF, Appella E: Complete amino acid sequence of a human monocyte chemoattractant, a putative mediator of cellular immune reactions. Proc Natl Acad Sci USA 1989, 86: 1850-1854
11. Berkhout TA, Sarau HIM, Moores K, White JR, Elshourbagy N, Appelbaum E, Reape TJ, Brawner M, Makwana J, Foley JJ, Schmidt DB, Imburgia C, McNulty D, Matthews J, O'Donnell K, O'Shannessy D, Scott M, Groot PHE, Macphee C: Cloning, in vitro expression and functional characterization of a novel human CC chemokine of the MCP famly (MCP-4), which binds and signals through the CC chemokine receptor 2B. J Biol Chem 1997, 272:16404-16413
12. Uguccioni M, D'Apuzzo M, Loetscher M, Dewald B, Baggiolini M: Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES. MIP-1α and MIP-1β on human monocytes. Eur J Immunol 1995, 25:64-68
13. Nelken NA, Coughlin SR, Gordon D, Wilcox JN: Monocyte chemoattractant protein-1 in human atheromatous plaques J Clin Invest 1991, 88:1121-1127
14. Ylá-Herttuala S, Lipton BA, Rosenfeld ME, Särkioja T, Yoshimura T, Leonard EJ, Witztum JL, Steinberg D: Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 1991, 88:5252-5256
15. Taub DD, Proost P, Murphy WJ, Anver M, Longo DL, VanDamme J, Oppenheim JJ: Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J Clin Invest 1995, 95: 1370-1376
16. Hieshima K, Imai T, Baba M, Shoudai K, Ishizuka K, Nakagawa T, Tsuruta J, Takeya M, Sakaki Y, Takatsuki K, Miura R, Opdenakker G, Van Damme J, Yoshie O, Nomiyama H: A novel human CC chemokine PARC that is most homologous to macrophage-inflammatory protein-1α/LD78α and chemotactic for T lymphocytes, but not for monocytes. J Immunol 1997, 159:1140-1149
17. Adema GJ, Hartgers F, Verstraten R, de Vries E, Marland G, Menon S, Foster J, Xu G, Nooyen P, McClanahan T, Bacon KB, Figdor CG: A dendritic-cell-derived C-C chemokine that preferentially attracts raive T cells. Nature 1997, 387:713-717
18. Yoshida R, Imai T, Hieshima K, Kusuda J, Baba M, Kitaura M, Nishimura M, Kakizaki M, Nomiyama H, Yoshie O: Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1. CCR7 J Biol Chem 1997, 272:13803-13809
19. Rossi DL, Vicari AP, Franz-Bacon K, McClanahan TK, Zlotnik A: Identification through bioinformatics of two new macrophage proinflammatory human chemokines MIP-3α and MIP-3β. J Immunol 1997, 158:1033-1036
20. Nagira M, Imai T, Hieshima K, Kusuda J, Ridanpaa M, Takagi S, Nishimura M, Kakizaki M, Nomiyama H, Yoshie O: Molecular cloning of a novel CC chemokine secondary lymphoid-tissue chemokine (SLC) that is a potent chemoattractant for lymphocytes and mapped to chromosome 9p13. J Biol Chem 1997, 272:19518-19524
21. Hieshima K, Imai T, Opdenakker G, Van Damme J, Kusuda J, Tei H, Sakaki Y, Takagi S, Nishimura M, Kakizaki M, Nomiyama H, Yoshie O: Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. J Biol Chem 1997, 272:5846-5853
22. Yoshie O, Imai T, Nomiyama H: Novel lymphocyte-specific CC chemokines and their receptors. J Leuk Biol 1997, 62:634-644
23. Yoshida R, Nagira M, Kitaura M, Imagawa N, Imai T, Yoshie O: Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7. J Biol Chem 1998, 273:7118-7122
24. Stemme S, Rymo L, Hansson GK: Polyclonal origin of T lymphocytes in human atherosclerotic plaques. Lab Invest 1991, 65:654-660
25. Manning CD, McLaughlin MM, Livi GP, Cieslinski LB, Torphy TJ, Barnette MS: Prolonged beta adrenoceptor stimulation up-regulates cAMP phosphodiesterase activity in human monocytes by increasing mRNA and protein for phosphodiesterases 4A and 4B. J Pharmacol Exp Ther 1996, 276:810-818
26. + dendritic cells. Proc Natl Acad Sci USA 1996, 93:2588-2592
27. Wilcox JN, Nelken NA, Coughlin SR, Gordon D, Schall TJ: Local expression of inflammatory cytokines in human atherosclerotic plagues. J Atheroscler Thromb 1994, 1 [Suppl 1]:S10-13
28. Koch AE, Kunkel SL, Pearce WH, Shah MR, Parikh D, Evanoff HL, Haines GK, Burdick MD, Strieter RM: Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic aneurysms. Am J Pathol 1993, 142:1423-1431
29. Pattison JM, Nelson PJ, Huie P, Sibley RK, Krensky AM: RANTES chemokine expression in transplant-associated accelerated atherosclerosis. J Heart Lung Transplant 1996, 15:1194-1199
30. Jordon NJ, Watson ML, Williams RJ, Roach AG, Yoshimura T, Westwick J: Chemokine production by human vascular smooth muscle cells: modulation by IL-13. Br J Pharmacol 1997, 122:749-757
31. John M, Hirst SJ, Jose PJ, Robichaud A, Berkman N, Witt C, Twort CHC, Barnes PJ, Fan Chung K: Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines: Regulation by T helper 2 cytokines and corticosteroids. J Immunol 1997, 158:1841-1847
32. Bobryshev YV, Lord RSA: S-100 positive cells in human arterial intima and in atherosclerotic lesions. Cardiovasc Res 1995, 29:689-696
33. Bobryshev YV, Lord RSA: Detection of vascular dentritic cells and extracellular calcium-binding protein S-100 in foci of calcification in human arteries. Acta Histochem Cytochem 1995, 28:371-380
34. Birkenbach M, Josefsen K, Yalamanchili R, Lenoir G, Kieff E: Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors. J Virol 1993, 67:2209-2220
35. Schweickart VL, Raport CJ, Godiska R, Byers MG, Eddy RL Jr, Shows TB, Gray PW: Cloning of human and mouse EBI1, a lymphoid-specific G-protein-coupled receptor encoded on human chromosome 17q12-q21.2. Genomics 1994, 23:643-450
36. Hansson GK: Cell-mediated immunity in atherosclerosis. Curr Opin Lipidology 1997, 8:301-311
37. Daugherty A, Puré E, Delfel-Butteiger D, Chen S, Leferovich J, Roselaar SE, Radar DJ: The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E -l-mice. J Clin Invest 1997, 100:1575-1580
38. Laman JD, de Smet BJGL, Schoneveld A, van Meurs M: CD40-CD40L interactions in atherosclerosis. Immunol Today 1997, 18:272-277
39. Mach F, Schönbeck U, Sukhova GK, Atkinson E, Libby P: Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 1998, 394:200-203
40. Campbell JJ, Hedrick J, Zlotnik A, Siani MA, Thompson DA, Butcher EC: Chemokines and the arrest of lymphocytes rolling under flow conditions. Science 1998, 279:381-383